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Fourier transform infrared spectrometry (FT-IR) and X-Ray diffraction (XRD) investigations 
were carried out on MLT plus α–, β– and γ–CD physical mixtures and lyophilized or crystalline 
MLT/α–,  β–, γ–CD complexes. Inclusion complexes formation between MLT and cyclodextrins 
in solid phase has been emphasized by the significant differences between IR and XRD spectra 
of physical mixtures with respect to those of the complexes. The structure of MLT CDs 
complexes in the solid state as well as the biochemical and pharmaceutical implications are 
discussed. 
 






Melatonin (MLT), is a quite ubiquitous molecule being present in practically all living organisms 
ranging from protista to reptiles and mammals. In humans, it is secreted during night by the 
pineal gland and it is involved in the regulation of various neuroendocrine physiologic cellular 
processes as well as several neural effectors1 almost connected with the circadian variation of 
daylight/night alternation and thus regulating sleep and seasonal reproduction cycles2. Melatonin 
has also recently come to footlights because it is the unique hormone which, being a strong anti-
oxidant, can act as powerful inhibiter of free radicals,3 scavenger of hydroxyl radicals,4 
lipoperoxyl radicals5, 6 and nitric oxide.7, 8 
At present, therapeutic applications of melatonin include circadian rhythm disorders,2 
cancer,9-11 AIDS,12 Alzheimer disease,13, 14 cataract15 and cardiac disease.16 Further, for its 
relevant biological properties that are also associated with an extremely low toxicity, melatonin 
could act as a drug for a number of other diseases.17, 18  
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For the properties above described, MLT finds a wide range of application in the 
pharmaceutical field. However its employment is limited by a low water solubility (0,002 
mol/kg)19 and by its relative sensitivity to light.  
Previous studies have been conducted on MLT and CDs in gas and solution phase.19, 20 Solid 
state interaction between MLT and CDs, have not been previously reported except for some 
patents21-23 that however deal with natural and derivatized CDs complex only and do not give 
any structural information about the complexes obtained 
Being an amphiphilic24 molecule, melatonin shows a marked tendency to locate, by means of 
non-covalent interactions, at the interface between polar and apolar regions.25 MLT location 
among hydrophobic chains would justify protective action of lipids from the attack of free 
radicals originated in the interior of membrane. Such observations are the basis of previous 
studies on MLT inclusion in α– β– and γ– cyclodextrin (CD) apolar cavities in aqueous 
solutions19 and gas phase.20 These studies evidenced MLT behavior in systems having a 
hydrophobic cavity surrounded by a hydrophilic region. Cyclodextrins are useful to mimic 
hydrophobic cavities present in various biological systems. Besides, they are able to host 
molecules having suitable sizes, through the formation of non-covalent bonds.26, 27 These 
inclusion complexes are of considerable scientific and technological interest. In fact through 
alcoholic residuals present in the external part of complex it is possible to solubilize in polar 
solvent even non polar molecules. Substantial improvement of various parameters including 
stability, bioavailability, release control and palatability are also achieved.28 In fact CDs are quite 
stable molecules made up by glucosidic residues which model a hydrophobic cavity, they resist 
to alkaline solutions but are sensible to strong acid solutions, which determine the ring opening. 
Generally CDs are useful to enhance the solubility of drugs in water and their clearance, to lower 
local and systemic toxicity and to act as artificial carrier for endogenous and exogenous 
lipophilic substances. In particular, β-cyclodextrin has been approved by the Food and Drug 
Administration and by European Community as alimentary low-cost additive.  
Inclusion complexes of various biologically active indole derivatives, such as 
indomethacin,29 tryptophan,30 methoxytryptamine31 and melatonin19, 20 have been previously 
investigated as well as the interactions of solid cyclodextrins with compounds of pharmaceutical 
interest. The aim of the present study is to ascertain the formation and stability of inclusion 
complexes of MLT with natural cyclodextrins in the solid phase and to investigate confinement 
effects of MLT in hydrophobic cavities simulating biological receptors. 
 
 
Results and Discussion 
 
FT-IR analysis of MLT/α–,  β–, γ–CD physical mixtures and complexes. FT-IR technique has 
been chosen to detect complex formation in solid phase and to emphasize the functional groups 
responsible of the solid MLT/CD complex stability. It has previously evidenced19 that the 
interactions established between MLT and CDs in aqueous phase are mainly hydrophobic, but 
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also some polar groups emerging from the cavity contribute to the complex stability, probably by 
the formation of hydrogen bonds, with outer rim hydroxyl groups. 
A comparison between FT-IR spectra of MLT, α–, β–, γ–cyclodextrins, physical mixtures 
and inclusion complexes, evidences some significant changes in the shape and position of the 
absorbance bands of MLT and CDs functional groups. 
In particular, for pure MLT as KBr solid dispersion, noteworthy differences have been 
observed respect to the IR spectrum of MLT CH2Cl2 dilute solution, being principal absorbance 
signals shifted toward higher wavenumbers (Table 1) . 
 
Table 1. Comparison of the principal differences between MLT at solid state and MLT CH2Cl2 
in dilute solution signals 
 MLT Crystals signals MLT CH2Cl2 Solution signals 
NH stretching 3284-3305 cm-1 3490-3460 cm-1 
CO double bond stretching 1627 cm-1 (twin band) 1670 cm-1 (single convoluted band) 
CH = CH indole stretching 1588 cm-1 1588 cm-1 
NH-CO bending 1556 cm-1 1520 cm-1 
C-O-CH3 bending 1213 cm-1 1213 cm-1 
 
Polar groups, as CO and indolic and amidic NH, capable to form strong hydrogen bonds, are 
those mainly implicated in the frequency signal shift with respect to the dilute solution in 
CH2Cl2. This is an indication that in solid phase both amidic NH and indolic amino groups as 
well as CO are involved in intermolecular hydrogen bonding. 
Superimposed e FT-IR spectra of α, β, γ cyclodextrins solid phas are shown in Figure 1. 
 
Figure 1. Solid phase natural cyclodextrin FT-IR spectra overlays. 
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The most interesting signals are: 
• Wide band at 3300-3600 cm-1 due to OH bonds stretching  
• A strong and complex band at 1000-1260 cm-1 due to C-O- bonds stretching 
The observation of the figure 2 that shows the superposition of FT-IR spectra of MLT and β-CD 
as pure substances, and both of β-CD/MLT as simple physical mixture and as complex evidences 
some noteworthy differences between the spectra. The most evident property is shown by the 1:1 
physical mixture spectrum of β-CD/MLT that is a complete superposition of the spectra of MLT 




Figure 2. Comparison between FT-IR spectra of MLT, β-CD/MLT 1:1 mixture and β-CD/MLT 
1:1 complex. 
 
The spectrum of the solid 1:1 complex β-CD/MLT is instead similar to that of pure β-CD, 
being the signals due to MLT quite completely convoluted and suppressed by the β-CD signals. 
Even the most strong peak due to NH stretching is convoluted and shifted toward 3284-3305  
cm-1. 
Other differences are present in the fingerprint region, where most of the MLT characterizing 
signals are shifted and modified. In particular: 
• (Amidic) carbonyl group CO stretching of MLT (twin peak at 1627 cm-1, Table 2), is still 
distinguishable in the physical mixture, but appears as single peak in the complex 
spectrum. This behaviour could be explained only admitting that the hydrogen bond 
involving the amidic CO is still maintained in the solid complex. However this implies that, 
while in the crystalline MLT hydrogen bonds are established between two MLT molecules, 
in the complex, a single MLT molecule should be inserted more or less deeply in the 
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hydrophobic cavity of the cyclodextrin. So in the complex a new hydrogen bond is formed 
between MLT and CD and in particular between primary OH of the outer (wider) rim and 
amide CO. 
• the sharp signal at 1556 cm-1, due to amide group (Table 1, Table 2) drastically reduces its 
intensity and sharpness in the complex. 
• C–OMe stretching signal at 1216 cm-1 (Table 2) is also quite disappeared in the complex 
spectrum, while it is perfectly maintained in the physical mixture spectrum. 
 
Table 2. Comparison of the principal differences between β-CD crystals signals, solid state, β-


















































All these findings reasonably confirm the formation of the inclusion complex between MLT 
and β-CD. In fact the comparison between physical mixture and complex evidences strong 
differences that can be explained considering that mainly resonance frequencies of the functional 
groups of MLT in the mixture are not changed, both in wavenumber and in probability due to the 
persistence of both species as crystals of β-CD and MLT each characterized by its own crystal 
structure maintained still intact. Instead the convolution and shifting of major peaks of MLT in 
the complex spectrum evidences a substantial variation of bond strength and length that 
obviously reflects on the IR absorbance resonance frequencies. The most interested signals are 
those due to the polar functional groups of MLT and β-CD, implying that in some extent, polar 
interaction can act as stabilising force in the complex formation. The quite complete 
disappearance of MLT signals is also a confirmation of the formation of an inclusion complex. In 
fact have been evidenced for some inclusion complexes32 a “shield” effect on the host molecule 
by CDs. This is probably due to dipole moment variation, in the complex structure that can be 
explained only considering that original pure substances crystal structure have been quite 
completely rearranged in the complex structure. Even if not directly evident by the single signal 
shifting and absorbance variation, a further information can be obtained by the whole complex 
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spectrum, widely similar to that of the pure β-CD: the final crystal structure should be at least 
similar to that of β-CD implying that the MLT should be included and not interposed between β-
CD molecules. 
Hydration effect on measures have been also investigated repeating experiments, on exposing 
in the oven (120°) to silica gel for variable times the complex obtained. Only minor spectra 
variations have been evidenced.  
Similar results have been obtained from MLT/α–CD (Figure 3) and MLT/γ–CD solid phase 
complexes (Figure 4).  
 
Figure 3. Comparison between FT-IR spectra of MLT, α–CD, α–CD/MLT mixture and 1:1 α–
CD/MLT complex. 
 
Figure 4. Comparison between FT-IR spectra of MLT, γ–CD, γ–CD/MLT mixture and 1:1 γ–
CD/MLT complex. 
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In fact band shift and shape modification of the same diagnostic signals previously described 
can be observed in the spectra of both the complexes. Shielding effect due to CDs as well as the 
same general pattern of the spectra that are closely related to that of the pure CDs confirm that 
inclusion complexes have been obtained. 
Accordingly to previous calorimetric data on solution phase complex, that allowed the 
determination of enthalpy, entropy and free energy and accordingly to 1H-NMR 2D-ROESY 
experiments,19 FT-IR data obtained in this investigation can be used to suggest the formation of 
inclusion complexes between MLT and CDs (Figure 5). The complex shape should remain even 
in the solid phase the same that have been previously described, with apolar interaction that also 
represent a strong cohesive force. But in the solid phase some additional hydrophilic non 
covalent interaction between CDs ring and MLT have been evidenced, that involve NH and CO 




Figure 5. Representation of the various inclusion modality of MLT in the investigated CDs. 
 
Wide angle X-ray scattering analysis. Further information upon MLT/α-, β-, γ-CD complexes 
have been achieved by wide angle X-ray scattering. 
In the case of MLT/β-CD complex as shown in figure 6 A and 6 B, both spectra of the 
complexes investigated β-CD/ MLT in the 1:1 e 2:1 ratios evidenced variation on the crystal 
structure that can justify the complex formation in the solid state. 
In particular the small auxiliary peaks with respect to β-CD and MLT diffraction patterns, at 
6.25°, implies a variation of intermolecular distances within the crystal lattice (Figure 6 A) as 
well as the complete disappearance of the MLT peak at 16° (Figure 6 B) points out that a new 
crystal structure have been obtained. 
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Figure 6. A: X-Ray diffraction patterns of MLT, β-CD, β-CD/MLT 1:1 mixture, β-CD/MLT 2:1, 
β-CD/MLT 1:1 in the range between 2° e 10° and B: X-ray powder diffraction patterns of MLT, 
β-CD, β-CD/MLT 1:1, β-CD/MLT 2:1, β-CD/MLT 1:1 physical mixtures and complexes. 
 
A careful analysis of the spectra suggests that the 1:1 MLT/β-CD complex shows small 
amount of pure MLT, that becomes negligible in the 2:1 complex. In the spectrum of the mixture 
between β-CD and MLT instead is evident a strong presence of uncomplexed MLT. A general 
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observation of the spectra, largely similar to that of β-CDs and completely different with respect 
to MLT, suggests also that crystal structure of the complexes should be similar to that described 
for β-CD, in fact similar signals both at low and wide angle indicate that intermolecular, more 
likely and interatomical distances, in lesser extent are quite super imposable. This aspect also 
implies that MLT should be included and not interposed between CD molecules. This latter case 
would imply a more substantial variation of complex crystal signals to respect with pure β-CD. 
The analysis of the diffraction patterns of α-CD/MLT (Figure 7) complex and of pure crystalline 
substances shows a behaviour similar to that described for β-CD/MLT complexes. Even in this 
case have been investigated both complexes with 1:1 and 2:1 α-CD/MLT ratios, and again slight 
but diagnostic variation of the X-ray spectra evidenced that new structures have been generated, 
different from those of the pure substances. 
 
Figure 7. X-ray powder diffraction patterns of MLT, α-CD, α -CD/MLT 1:1, α -CD/MLT 2:1, α 
-CD/MLT 1:1 physical mixtures and complexes.  
 
The most interesting variation is the lowering in complexes and physical mixture of the 16° 
peak diagnostic for the presence of pure MLT crystals. The peak is lowered but detectable in the 
physical mixture of MLT and α-CD, is even lower but still present in the α-CD/MLT 1:1 
complex, while is practically absent in the spectrum of the α-CD/MLT 2:1 complex. This finding 
suggests that the stoichiometry 1:1 is not sufficient to entirely complex the MLT, while a 
complete inclusion is achieved by increasing the relative amount (excess) of α-CD and besides 
that the formation of α-CD/MLT complexes can be made in some extent by simple kneading. 
This finding is also confirmed by the loss and shift of some other MLT diagnostic peaks at 
10,25° and 18,8° respectively. As for β-CD/MLT the aspect of the spectra of the complexes and 
above all the strict similarity with pure α-CD ones suggests the inclusion of the molecule in the 
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hydrophobic cavity of α-CD. Besides, the low peak intensities of the α–CD/MLT complexes 
suggest that the structural perturbation due to the MLT inclusion involves a marked loss in 
crystallinity of α-CD which is, for steric reasons, more significant than that of β- and γ-CD. 
The diffractograms obtained from γ-CD and MLT as pure substances (Figure 8), as mixture 
and as complex clearly reveal substantial differences between the pure substances ad final 
complex obtained. Noteworthy is the fact that with this kind of cyclodextrin the complete 
disappearance of the peak at 16° (diagnostic for crystalline MLT) have been achieved with the 
stoichiometry 1:1. The substantial difference between complex and physical mixture, that 
perhaps contains itself inclusion complexes formed during kneading, confirm the presence of a 




Figure 8.X-ray powder diffraction patterns of MLT, γ-CD, γ -CD/MLT 1:1, γ -CD/MLT 2:1, γ -
CD/MLT 1:1 physical mixtures and complexes. 
A more critic examination of the diffractrogram that lacks of many sharp peaks, and finally is 
fundamentally different from other species, could account for a not perfectly crystallized adduct, 
as well as the presence of more complicated inclusion complex formation. Lack of the peak at 
16° does not completely rule out the maintaining of two different crystalline species (MLT and 
γ-CD), however the lack of other MLT diagnostic peak does not support the presence of such 
crystals. Strong differences in the low angle region can be only justified by a consistent variation 
of the final crystal reticulum with respect to that of the pure γ-CD, this could be due to a 
conformational variation induced by MLT on the cone-shaped γ-CD form that results in a 
different packaging of the crystals.  
However an amorphous form, even in mixture with crystals cannot be excluded at this stage.  
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Conclusions 
 
In this work using FT-IR and X-Ray diffraction has been ascertained that MLT can form, even in 
the solid phase, non covalent complexes with natural CDs. In fact an evidence of inclusion 
complexes formation between MLT and cyclodextrins in solid phase has been shown by the 
considerable differences of IR spectra of physical mixture with respect to those of the 
complexes.  
Complexes formation has been also studied through crystallographic investigation. Powder 
X-ray diffraction patterns of the three inclusion complexes formed by MLT and α- β- and γ-CD, 
of mechanical mixture of the crystalline substances in the 1:1 ratio and of complexes formed 
through crystallization from solutions containing CDs and MLT in the 1:1 and 2:1 ratios 
respectively, evidence variations of the crystalline structure which also justify inclusion complex 
formation in solid state. 
It is also worth to note that inclusion complexes formation between MLT and CD have been 
observed also in solution and gas phase and thus not limited to a particular phase or condition. It 
has previously described26 that cyclodextrin can be used as model to mimic hydrophobic sacks in 
membranes in cell, and this kind of interaction makes reasonable to suppose that in biological 
systems MLT could be localized preferentially in hydrophobic sacks present in cell membranes. 
Similar results have been also achieved by analysis of MLT containing anhydrous micellar 
systems.33 These data can justify also the strong protection effect, almost against free radicals, of 
MLT on cell membranes, that have been reported.4-8  
Infrared spectra on the solid complex demonstrated that in the formation of inclusion 
complexes an important contribution is due to polar bonds formation-modification, thus 
evidencing once more33 that MLT is preferentially localised in interfacial nano-districts, between 





General Procedures. Melatonin (Aldrich St. Louis, MO, USA, 99.5%), α, β, γ-cyclodextrins 
(Fluka, Buchs, Switzerland, 99.5%), water (Fluka, HPLC grade), potassium bromide (Fluka, 
98%), dichloromethane (J.T.Baker, Phillipsburg, NJ, USA, 99%) were used without any further 
purification. 
FT-IR spectra in solution were recorded with a Bruker (Karlsrue, Germany) IFS25 FT-IR 
spectrometer, using a cell equipped with CaF2 windows. For all measurements 100 scans in the 
800-4000 cm-1 wavenumber range were carried out. All spectra were recorded at 25°C and with a 
spectral resolution of 1 cm–1. FT-IR spectra of solid state samples as KBr dispersions pressed 
disks, have been recorded in the 400–4000 cm-1 spectral region with a Perkin Elmer Spectrum 
RX I FT-IR spectrometer. 
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Powder X-ray diffraction patterns have been collected in the 2-80 degree range using a 
Philips (PW1050/39 X Change) diffractometer provided of a copper anode (Cu, Kα = 1.5418 Å).  
Inclusion complexes were prepared accordingly to two different procedures, as explained 
below.  
• Lyophilized complexes were prepared by mixing opportune volume of a MLT solution 
(0,002 M) with a weighed quantity of CD. In order to speed up dissolution of the CD, and 
particularly in the case of β-CD, the resulting initial dispersion deposed in an ultrasonic bath 
for 15 minutes. The resulting clear solution finally frozen and at last freeze dried with a 
Edward Modulyo apparatus.  
• Crystalline complexes were prepared even in this case by mixing opportune volume of a 
MLT solution (0,002 M) with weighed quantities of CD and the same ultrasonic treatment 
was used to speed up CD dissolution. The resulting clear solution was put in a dark 
desiccator, and finally dried for three days under vacuum in complete darkness, using a 
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